Compare AMLX & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMLX | CNOB |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2021 | N/A |
| Metric | AMLX | CNOB |
|---|---|---|
| Price | $13.90 | $26.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $20.11 | ★ $30.33 |
| AVG Volume (30 Days) | ★ 867.2K | 313.4K |
| Earning Date | 03-03-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | $42.85 |
| Revenue Next Year | N/A | $7.27 |
| P/E Ratio | ★ N/A | $17.02 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $3.11 | $20.61 |
| 52 Week High | $17.49 | $29.28 |
| Indicator | AMLX | CNOB |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 54.82 |
| Support Level | $13.36 | $25.88 |
| Resistance Level | $15.37 | $27.16 |
| Average True Range (ATR) | 0.74 | 0.66 |
| MACD | -0.08 | 0.12 |
| Stochastic Oscillator | 48.17 | 87.19 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.